Prognostic significance of TGF-α expression in breast cancer

Acta Oncologica

Volumn 35, Issue 8, 1996, Pages 995-998

  Auvinen, Päivi K ^a,b   Lipponen, Pertti K ^a   Kataja, Vesa V ^b   Johansson, Risto T ^b   Syrjänen, Kari J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0030497629     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609100717     Document Type: Article

References (22)

1. Derynck R. Transforming growth factor alfa. Cell 1988; 54: 594-5.
2. Bates S, Davidson N, Valverius E, et al. Expression of transforming growth factor alfa and its messenger ribonuklei acid in human breast cancer: its regulation by estrogen and its possible funktional significance. Mol Endocrinol 1988; 2: 543-55.
3. Lupu R, Wellstein A, Sheridan J, et al. Purification and characterization of a novel growth factor from human breast cancer cells. Biochemistry 1992; 31: 7330-40.
4. Salomon D, Zwiebel J, Bano M, Losonczy I, Fehnel P, Kidwell W. Presence of transforming growth factor in human breast cancer cells. Cancer Res 1984; 44: 4069-77.
5. Ahmed S, Badger B, Wright C, Manni A. Role of transforming growth factor-α (TGF-α) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-α and EGF receptor antibodies. J Steroid Biochem Molec Biol 1991; 38: 687-93.
6. Marquardt H, Hunkapiller MW, Hood L, Todaro G. Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 1984; 223: 1079-82.
7. Auvinen P, Lipponen P, Johansson R, Syrjänen K. Prognostic significance of TGF-β1 and TGF-β2 expressions in female breast cancer. Anticancer Res 1995; 15: 2627-32.
8. Auvinen P, Lipponen P, Johansson R, Syrjänen K. Prognostic significance of TGF-β2 expression in female breast cancer. Eur J Cancer 1995; 31: 831.
9. WHO. Histologic typing of breast tumours. International histological classification of tumours No2, 2nd, Geneva: World Health Organization, 1981.
10. Bloom H, Richardson W. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-77.
11. Eskelinen M, Lipponen P, Papinaho S, et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 1992; 51: 555-61.
12. Vihko R, Jänne O, Kontula R, Syrjälä P. Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels. Int J Cancer 1980; 26: 13-21.
13. Tervahauta A, Syrjänen S, Yliskoski M, Gold L, Syrjänen K. Expression of transforming growth factor-β1 and -β2 in human papillomavirus (HPV)- associated lesions of uterine cervix. Gynecol Oncol 1994; 54: 349-56.
14. Kaplan E, Meier P. Nonparametric estimates for incomplete observations. J Am Stat Assoc 1958; 53: 456-81.
15. Cox D. Regression models and life tables with discussion. J R Stat Doc B 1972; 34: 187-220.
16. Ciardiello F, Kim N, McGeady, et al. Expression of transforming growth factor alpha (TGFα) in breast cancer. Annals of Oncology 1991; 2: 169-82.
17. Panico L, Dàntonio A, Salvatore G, et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and cripto in human normal and malignant breast tissues. Int J Cancer 1996; 65: 51-6.
18. Umekita Y, Enokizono N, Sagara Y, et al. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF. TGF-αlpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status. Virchows Archiv A Pathol Anat 1992; 420: 345-51.
19. Murray P, Barrett-Lee P, Travers M, Luqmani Y, Powles T, Coombes R. The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 1993; 67: 1408-12.
20. Van Agthoven T, Timmermans M, Foekens J, Dorssers L and Henzen-Logmans S. Differential expression of estrogen, progesterone and epidermal growth factor receptors in normal, benign and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 1994; 144: 1238-46.
21. Nicholson R, McClelland R, Gee J, et al. Transforming growth factor-alpha and endocrine sensitivity in breast cancer. Cancer Res 1994; 54: 1684-9.
22. Manni A, Wright C, Buck H. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat 1991; 20: 43-52.